OptimizeRx Corp expected to post earnings of 6 cents a share - Earnings Preview

OptimizeRx

12/11/2024 03:47

* OptimizeRx Corp  OPRX.OQ   OPRX.O  is expected to show a
rise in
quarterly revenue when it reports  results on November 13 for
the period ending September 30 2024
    * The Waltham Massachusetts-based  company is expected to
report a
53.1% increase in revenue to $24.997 million from $16.33 million
a year ago, according to the mean estimate from 7 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for OptimizeRx Corp is for
earnings of 6 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for OptimizeRx
Corp
is $15.00​, above​ its last closing price of $6.06. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.06       -0.06      0.02      Beat    131.3
 Jan. 1 2024   -0.12       -0.13      -0.11     Beat    13.7
 Dec. 31 2023  0.33        0.32       0.26      Missed  -19.5​
 Sep. 30 2023  0.03        0.03       0.09      Beat    260
 ​​Jun.        -0.02       -0.02      -0.01     Beat    53.3
 30 2023                                                
 Mar. 31 2023  -0.08       -0.08      -0.09     Missed  -12.5​
 Dec. 31 2022  0.25        0.24       0.25      Beat    3.6
 Sep. 30 2022  0.03        0.04       0.07      Beat    90.7
 This summary was machine generated November 12 at 03:47 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)